[Therapy of Waldenström disease].
D000743:Anemia, Hemolytic / Q000150:complications; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001809:Blood Viscosity; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006474:Hemorrhagic Disorders / Q000150:complications; D006801:Humans; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy*; D005719:gamma-Globulins / Q000627:therapeutic use
D000970:Antineoplastic Agents; D005938:Glucocorticoids; D005719:gamma-Globulins; D002699:Chlorambucil; D003520:Cyclophosphamide
Therapie des Morbus Waldenström.